Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients.
Saved in:
| Title: | Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients. |
|---|---|
| Authors: | Jelínek, Tomáš1, Maisnar, Vladimír2, Pour, Luděk3, Špička, Ivan4, Minařík, Jiří5, Gregora, Evžen6, Kessler, Petr7, Sýkora, Michal8, Fraňková, Hana9, Adamová, Dagmar10, Wróbel, Marek11, Mikula, Peter12, Jarkovský, Jiří13, Diels, Joris14, Gatopoulou, Xenia15, Veselá, Šárka16, Besson, Hervé14, Brožová, Lucie13, Ito, Tetsuro17, Hájek, Roman18 roman.hajek@fno.cz |
| Source: | Current Medical Research & Opinion. May2018, Vol. 34 Issue 5, p775-783. 9p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
